RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT

NCT03412409 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: Cytarabine

Sponsor

Peking University People's Hospital